leisure time -WSS

leisure time

author：entertainment 2025-09-27 16:22:47 - browse：7

Beam Therapeutics said Thursday morning it would lay off 20% of its staff — or around 100 employees — and pause or reevaluate certain programs as it looks to cut costs.

It’s a notable setback for a gene-editing company that quickly raised over $1 billion in the few years after its co-founder, David Liu, described a new form of CRISPR, called base editing, that allowed researchers to change individual letters of DNA. The biotech hired rapidly, announced its intention to treat a broad range of diseases, and received clearance to start clinical trials in cancer and sickle cell.

Beam, however, has struggled to enroll patients in those trials. Meanwhile, the biotech stock market has stayed cold, including for gene-editing companies, whose technologies raise new regulatory, safety, and reimbursement questions. The pending approval of two gene therapies for sickle cell would also limit the market for Beam’s lead drug.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Group opposing PBM reform sets lobbying record

explore

WSS

Custom gene therapy hints at new path for rare disease treatments

New definition of a human embryo proposed amid rapid advances

Beware the threat of staffing cuts at the CDC

Baltimore teen accused of firing into crowd during block party mass shooting

FDA approves first treatment for ultra

In early work, researchers turn to CRISPR to treat Alzheimer's

knowledge

leisure time

hotspot

Apple is now the first public company to be valued at $3 trillion

How dance can help nurses traumatized by Covid

Psychedelics group wrestles with new pharma identity

Liz Cheney makes 1st public comment since Trump's election interference indictments

ChatGPT in medicine: STAT answers readers' burning questions

Listen: Wegovy in the brain & pivotal Alzheimer's data

As demand for Covid shots wanes, Moderna seeks its next success

Sanders adds drug shortage policies to pandemic preparedness bill

Sports medicine is finally prioritizing gender equality

Eye stem cell transplant could help restore vision in injured people

focus

The pain doctors face in trying to build their families

Google and Epic fight stronger regulation of AI in health care

Trump cancels press conference intended to dispute Georgia election interference charges

Doctors find melanoma drugs effective against rare brain cancer

An interview with Robert F. Kennedy Jr. on vaccines

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

explore

entertainment

leisure time

knowledge